Sterile Injectable Drugs Market to Record Exponential Growth During Projected Timeframe – ZMR

Zion Market Research has published a new report titled “Sterile Injectable Drugs Market by Type (Small Molecules and Large Molecules), by Drug Class (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Vaccine, Immunoglobulin, Blood Factors, and Others), by Indication (Cardiology & Metabolic Disorders, Musculoskeletal, Neurology, Oncology, Autoimmune, Infectious Diseases, and Others), and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017—2024”. According to the report, the global sterile injectable drugs market was valued at approximately USD 369.7 billion in 2017 and is expected to generate around USD 779.9 billion by 2024, at a CAGR of around 11.25% between 2018 and 2024.

The increasing preference for large molecule drugs over traditional drugs, rising incidences of chronic diseases, and the requirement of large molecules for the treatment of chronic diseases are major growth factors likely to fuel the sterile injectable drugs market in the future. The rise in the use of biologics, monoclonal antibodies, and antibody-drugs conjugate to treat various diseases is also anticipated to boost the development of this market globally in the estimated time period.

The sterile injectable drugs market is divided based on type, indication, drug class, and distribution channel. By type, the market is classified into large molecules and small molecules. Large molecules are anticipated to dominate the sterile injectable drugs market. The indication segment comprises musculoskeletal disorders, neurology, oncology, autoimmune, contagious diseases, cardiology and metabolic disorders, and others. Oncology is expected to dominate this market globally, due to the rising prevalence of cancer and research on the effective drugs for treating cancer. By drug class, the sterile injectable drugs market includes insulin, vaccine, peptide hormones, monoclonal antibodies, immunoglobulin, cytokines, blood factors, and others. Monoclonal antibodies are likely to lead this global market, as they can bind to the same epitope through monovalent affinity and carry drugs to help them in triggering the immune system for required responses. By distribution channel, the market includes hospital pharmacy, retail pharmacy, and e-commerce. Hospital pharmacies are projected to dominate the market in the future, owing to the major patient population in hospitals.

Get Sample of this Research Report – https://www.zionmarketresearch.com/sample/sterile-injectable-drugs-market

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa comprise the regional segment of the global sterile injectable drugs market. The Asia Pacific is predicted to register the highest rate of growth in the sterile injectable drugs market, owing to the presence of a large patient pool, the presence of various small pharma companies in India and China, the introduction of different types of policies by various government bodies, and rising awareness about sterile injectable drugs. North America is projected to lead the market for sterile injectable drugs in the forecast time period, due to the rapid developments made in healthcare infrastructure, the presence of major players in the region, and huge investments made in the research and development. The increase in investment witnessed across the healthcare sector, the enforcement of strict government regulations for sterile injectable drugs, and rise in the prevalence of chronic diseases are likely to support this market in the European region.

Browse TOC of this Report – https://www.zionmarketresearch.com/toc/sterile-injectable-drugs-market

Major players of the sterile injectable drugs market include GlaxoSmithKline PLC, Baxter International Inc., AstraZeneca, Johnson & Johnson Services, Inc., Sanofi, Merck & Co., Inc., Gilead Sciences Inc., Pfizer Inc., Novartis AG, and Nova Nordisk A/S, among others.

This report segments the global sterile injectable drugs market into:

Global Sterile Injectable Drugs Market: Type Analysis

• Small Molecules
• Large Molecules

Global Sterile Injectable Drugs Market: Drug Class Analysis

• Monoclonal Antibodies
• Cytokines
• Insulin
• Peptide Hormones
• Vaccine
• Immunoglobulin
• Blood Factors
• Others

Global Sterile Injectable Drugs Market: Indication Analysis

• Cardiology and Metabolic Disorders
• Musculoskeletal Disorders
• Neurology Disorders
• Autoimmune
• Oncology
• Infectious Diseases
• Others

Global Sterile Injectable Drugs Market: Distribution Channel Analysis

• Hospital Pharmacy
• Retail Pharmacy
• E-Commerce

Global Sterile Injectable Drugs Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.